title: Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein.
abstract: Smoking impairs the endothelium-dependent relaxation of arteries and veins, with the maximum relaxation in response to the calcium ionophore A23187 of saphenous vein rings being reduced from 53 +/- 4% in nonsmokers to 27 +/- 5% in smokers. We have investigated whether this endothelial dysfunction was attributable to altered activity or concentration of nitric oxide synthase (NOS). The concentration of NOS in saphenous vein endothelium, determined by Western blotting and immunohistochemistry, was not different in nonsmokers and smokers. Nitrite production from vein strips stimulated with A23187 was higher in nonsmokers (median 23.6 nmol.cm-2.h-1) than smokers (median 3.3 nmol.cm-2.h-1), P=.001, this difference being abolished when vein strips were preincubated in the presence of NG-monomethyl-L-arginine. Organ chamber studies to monitor the endothelium-dependent relaxation of vein rings in response to A23187 showed that preincubation of rings from smokers with either L-arginine (3mmol/L) or superoxide dismutase (250 U/mL) did not improve the maximum relaxation. In contrast, preincubation of vein rings from smokers with 20 micromol/L tetrahydrobiopterin increased the maximum relaxation from 27 +/- 5% to 51 +/- 6%, P=.01. Preincubation of vein from smokers with tetrahydrobiopterin also significantly increased nitrite and cGMP production in response to stimulation with A23187. The impaired endothelium-dependent relaxation of saphenous vein rings from smokers appears to be caused by a reduction in the activity of endothelial NOS that is attributable to an inadequate supply of the coenzyme tetrahydrobiopterin.
authors.affiliation: Department of Surgery, Charing Cross & Westminster Medical School, London, UK.
authors.forename: D J
authors.initials: DJ
authors.lastname: Higman
authors.forename: A M
authors.initials: AM
authors.lastname: Strachan
authors.forename: L
authors.initials: L
authors.lastname: Buttery
authors.forename: R C
authors.initials: RC
authors.lastname: Hicks
authors.forename: D R
authors.initials: DR
authors.lastname: Springall
authors.forename: R M
authors.initials: RM
authors.lastname: Greenhalgh
authors.forename: J T
authors.initials: JT
authors.lastname: Powell
mesh_terms: D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives / Q000494:pharmacology; D015153:Blotting, Western; D000001:Calcimycin / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism; D016232:Endothelins / Q000378:metabolism; D004730:Endothelium, Vascular / Q000201:enzymology* / Q000502:physiology / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007476:Ionophores / Q000494:pharmacology; D008297:Male; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D009573:Nitrites / Q000378:metabolism; D009924:Organ Culture Techniques; D012501:Saphenous Vein / Q000166:cytology / Q000201:enzymology* / Q000502:physiology; D012907:Smoking / Q000009:adverse effects*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
chemical_list: D016232:Endothelins; D007476:Ionophores; D009573:Nitrites; D001708:Biopterins; D000001:Calcimycin; D019001:Nitric Oxide Synthase; C003402:sapropterin; D006152:Cyclic GMP